Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii

Mycoses

Volumn 56, Issue 3, 2013, Pages 397-401

  Brilhante, R S N ^a   Caetano, E P ^a   Sidrim, J J C ^a   Cordeiro, R A ^a   Camargo, Z P ^b   Fechine, M A B ^a   Lima, R A C ^a   Castelo Branco, D S C M ^a   Marques, F J F ^a   Mesquita, J R L ^c   Lima, D T ^a   Monteiro, A J ^a   Rocha, M F G ^a,d  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital São José for Infectious Diseases   (Brazil)

^d STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Antifungal drugs; Ciprofloxacin; Dimorphic fungi; Minimum inhibitory concentration reduction

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CIPROFLOXACIN; ITRACONAZOLE; VORICONAZOLE;

ARTICLE; BROTH DILUTION; COCCIDIOIDES; COCCIDIOIDES POSADASII; CONTROLLED STUDY; DRUG POTENTIATION; FUNGUS GROWTH; HISTOPLASMA CAPSULATUM; IN VITRO STUDY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CIPROFLOXACIN; COCCIDIOIDES; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; ECHINOCANDINS; HISTOPLASMA; MICROBIAL SENSITIVITY TESTS; MYCELIUM; PYRIMIDINES; TRIAZOLES;

COCCIDIOIDES POSADASII; FUNGI; HISTOPLASMA CAPSULATUM VAR. CAPSULATUM;

EID: 84876339432     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12025     Document Type: Article

References (16)

1. Cordeiro RA, Brilhante RSN, Rocha MFG et al. Twelve years of coccidioidomycosis in Ceará State, Northeast Brazil: epidemiologic and diagnostic aspects. Diagn Microbiol Infect Dis 2009; 66: 65-72.
2. Kauffman CA. Histoplasmosis. Clin Chest Med 2009; 30: 217-25.
3. Cordeiro RA, Brilhante RSN, Rocha MFG et al. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents 2009; 34: 278-80.
4. Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 2005; 40: 1770-6.
5. Wheat LJ, Connolly P, Smedema M et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother 2006; 57: 1235-9.
6. Kriesel JD, Sutton DA, Schulman S, Fothergill AW, Rinaldi MG. Persistent pulmonary infection with an azole-resistant Coccidioides species. Med Mycol 2008; 46: 607-10.
7. Shen LL, Baranowski J, Fostel J, Montgomery DA, Lartey PA. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs. Antimicrob Agents Chemother 1992; 36: 2778-84.
8. Nakajima R, Kitamura A, Someya K, Tanaka M, Sato K. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob Agents Chemother 1995; 39: 1517-21.
9. Brilhante RSN, Fechine MAB, Cordeiro RA et al. In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum. Antimicrob Agents Chemother 2010; 54: 3978-9.
10. Stergiopoulou T, Meletiadis J, Sein T et al. Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob Agents Chemother 2008; 52: 2196-204.
11. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
12. Sugar AM, Liu XP, Chen RJ. Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs. Antimicrob Agents Chemother 1997; 41: 2518-21.
13. Sasaki E, Maesaki S, Miyazaki Y et al. Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans. J Infect Chemother 2000; 6: 151-4.
14. Deren YT, Özdek S, Kalkanci A, Akyürek N, Hasanreisoǧlu B. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits. Can J Microbiol 2010; 56: 1-7.
15. Sugar AM, Liu XP. Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles. Antimicrob Agents Chemother 2000; 44: 2004-6.
16. Stergiopoulou T, Meletiadis J, Sein T et al. Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus. J Antimicrob Chemother 2009; 63: 343-8.